Switzerland · Series B startup

Who invested in Hemotune

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$16Mraised across 1 round since 2024, from 1 source

Latest round
Series B, $16MMar 2024
Investors
6
See who backed them

The rounds

  1. Mar 2024

Founders and team

From Hemotune's own website: 2 founders, 4 on the team.

Lukas LangeneggerCEO, Board Member and Co-founder
Dr. Carlos MoraCTO and Co-founder
  • Christian BrühlmannChief Business Officer
  • Dr. Jean-Claude MetzgerHead of Product Development
  • Dr. Stephanie SauterHead of Clinical Affairs
  • Dr. Ursina HaltinnerHead of Regulatory & Quality Affairs

Everyone who backed them

EISMEAInvestment firm1round
Venture KickAccelerator1round
InnosuisseGovernment1round
EIT HealthVC firm1round
EurostarsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Hemotune as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

OCCIDENTVC firmPer its own site
VP Venture PartnersVC firmPer its own site
EFI Lake Geneva VenturesVC firmPer its own site

Quick answers about Hemotune

Who invested in Hemotune?

Hemotune's investors include EISMEA, Venture Kick, Innosuisse, EASME - EU Executive Agency for SMEs and EIT Health, and 1 more on record.

How much has Hemotune raised?

Hemotune has raised $16M across 1 round since 2024.

When did Hemotune last raise?

Hemotune's most recent round was a Series B of $16M in Mar 2024.

What was Hemotune's biggest round?

Its most recent round, $16M in Mar 2024, is also its largest on record.

Who backed Hemotune first?

Hemotune's first round on record, in Mar 2024, was backed by EISMEA, Venture Kick and Innosuisse and 3 others.

What stage is Hemotune at?

Hemotune's latest named round is a Series B, in Mar 2024.

Where is Hemotune based?

Hemotune is based in Switzerland.

Companies like Hemotune

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.